All Articles

Gut bioengineered models to study host-microbiota-probiotics interactions

Probiotic membrane vesicles: emerging tools for disease treatment

Host-dependent alteration of the gut microbiota: the role of luminal microRNAs

Potential effects of probiotics on atherosclerosis

Potential applications of engineered bacteria in disease diagnosis and treatment

Pathogen exclusion from intestinal mucus and antimicrobial susceptibility of Bifidobacterium spp. strains from fecal donors

Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases

Comparative genome analysis of microbial strains marketed for probiotic interventions: an extension of the Integrated Probiotic Database

Effect of protein modification in synbiotic infant formula on probiotic metabolic activity and bacterial composition in an infant gut-model

Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis

A value chain to improve human, animal and insect health in developing countries

Gut microbiota resilience and recovery after anticancer chemotherapy

The importance of the timing of microbial signals for perinatal immune system development

The human microbiome project at ten years - some critical comments and reflections on “our third genome”, the human virome

Perspective: microbial interventions in the urinary tract

The gut-immune-brain axis in neurodevelopment and neurological disorders

Probiotic colonization dynamics after oral consumption of VSL#3^® by antibiotic-treated mice

Bifidobacteria: insights into the biology of a key microbial group of early life gut microbiota